Overriding the Immune System’s Brakes without Crashing

red_traffic_light_green_traffic_light
Share

There are now many types of anti-cancer drugs that target the immune system, including those that override the immune system’s natural regulatory processes. These processes function as the brakes on the immune system. The FDA-approved immune checkpoint inhibitors are Keytruda (pembrolizumab), Opdivo (nivolumab), Tecentriq (atezolizumab), and Yervoy (ipilimumab). Several investigational drugs [MK-4166, GWN323, MS-986156, INCAGN01876, … Read moreOverriding the Immune System’s Brakes without Crashing

Share

Fighting Cancer with the Immune System: Lessons from CAR T Cell Therapy

CAR_T_Cells
Share

The Promise of CAR T Cell Therapy Many strategies that train the immune system to recognize and attack cancer are in development or undergoing clinical trials (1). However, these strategies have the potential to cause life-threatening consequences, as evidenced by the latest report of the death of another patient receiving CAR T cell therapy (2). CAR … Read moreFighting Cancer with the Immune System: Lessons from CAR T Cell Therapy

Share

Can Denosumab Prevent Breast Cancer?

Structure_model_denosumab_OPG_RANKL
Share

From Osteoporosis to Breast Cancer Denosumab, a biologic agent, and bisphosphonates, which are small molecule drugs, reduce fractures that are complications of osteoporosis, including those caused by breast cancer hormone therapies that block estrogen signaling, menopause, or surgically-induced menopause (oophorectomy with or without hysterectomy). Both denosumab and bisphosphonates also reduce the risk of bone metastasis … Read moreCan Denosumab Prevent Breast Cancer?

Share